Pancreas cells may produce a protein that can protect the brain from Alzheimer's disease. In individuals with Alzheimer's disease, a peptide known as amyloid-β accumulates and forms tangled plaques. People with diabetes have a higher probability of developing Alzheimer's disease, raising the possibility of a link between the cells that are disordered in diabetes—pancreatic β cells—and the onset of Alzheimer's disease. However, insulin supplementation may not halt the development of Alzheimer's disease. Toru Hosoi and colleagues hypothesized the existence of a neuroprotective agent secreted by pancreatic β cells, distinct from insulin, that could mitigate the onset of Alzheimer's disease. The authors cultured mouse pancreatic β cells, then exposed neuronal cells treated with amyloid-β to liquid from the pancreatic β cells. The liquid effectively stopped amyloid-β-induced neuronal cell death. The neuroprotective factor at work is thought to be Fibroblast Growth Factor 23 (FGF23), an endocrine protein. Treating neuronal cells subjected to amyloid-β with FGF23 alone significantly reduced cell death from amyloid-β toxicity. According to the authors, FGF23 may increase ribosomal proteins, helping to maintain the homeostasis of ribosomal components in neurons.
Pancreas Cells Release Neuroprotective Factor
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.